Pre- and post-irradiation mild hyperthermia enabled by NIR-II for sensitizing radiotherapy

Quan Li1, Lifeng Hang2, Wei Jiang2

  • 1Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China; Guangzhou Women and Children's Medical Center, Guangzhou, 510623, China.

Biomaterials
|August 1, 2020
PubMed
Summary

This study introduces a dual-hyperthermia strategy using PEGylated nanobipyramids to enhance cancer radiotherapy. This approach relieves tumor hypoxia and prevents DNA repair, significantly improving treatment efficacy.